Sabah Kadri

机构：AbbVie (United States) · ORCID：0000-0003-0365-6550

发表论文 133 篇 · 总被引 4077 次 · h-index 28

代表论文

• The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment (2025 · Toxicological Sciences · 被引 9)
• Clinical Bioinformatician Body of Knowledge—Bioinformatics and Software Core (2025 · Journal of Molecular Diagnostics · 被引 5)
• Development of a Body of Knowledge for the Clinical Bioinformatician (2024 · Journal of Molecular Diagnostics · 被引 2)
• Optimization of Genome-Wide CRISPR Screens Using Dual-Guide RNA Infection with Cas9 Electroporation (DICE) (2026 · The CRISPR Journal · 被引 1)
• Monozygotic twins discordant for juvenile dermatomyositis: clinical, serological and gene expression studies (2025 · Pediatric Rheumatology)
• PP8.9 – 00016 T Cell Receptor Repertoire Profiling in Phase 1b Study with PD-1 Inhibitor, Budigalimab, in PLWH Undergoing Analytical Treatment Interruption (2024 · Journal of Virus Eradication)